Ensuring participant safety and trial integrity with clinical trials oversight.

Publication Type:

Journal Article


Journal of acquired immune deficiency syndromes (1999), Volume 65 Suppl 1, p.S40-3 (2014)


2014, January 2014, Vaccine and Infectious Disease Division


Clinical trial oversight is a critical element that ensures the protection of research participants and integrity of the data collected. The trial sponsor, a local Institutional Review Board, and independent monitoring committees all contribute with complementary but overlapping responsibilities. Consistency among these groups is essential for the smooth conduct of a clinical trial but may be challenging in resource-limited settings (RLS). Capacity building and training for RLS may improve clinical trials oversight and ultimately medical management. In this article, we review the components necessary for optimal clinical trial oversight and the issues that arise in the RLS, with some suggested strategies for improvement.